Why is QMS Medical falling/rising?

As of 29-Jul, QMS Medical Allied Services Ltd is currently priced at 79.00, reflecting an increase of 4.3 or 5.76%. Today's price summary indicates that the stock has outperformed its sector by 5.32%, despite trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages. Over the past week, the stock has seen a decline of 2.47%, and a more significant drop of 6.56% over the past month. However, it is noteworthy that the stock's delivery volume has surged by 368.75% compared to the 5-day average, suggesting rising investor participation. While the company reported positive quarterly results, including the highest PBDIT of Rs 7.83 cr and a 41.3% growth in PBT, it has also faced challenges with a long-term growth rate of only 4.40% in net sales over the past five years, contributing to its -33.59% return over the last year.
In the broader market context, QMS Medical's recent performance contrasts with the Sensex, which has declined by only 0.96% over the past week and 3.19% over the past month. The stock's significant underperformance relative to the benchmark over the past year and three years highlights its struggles in both short-term and long-term growth. Despite the attractive valuation indicated by a PEG ratio of 0.8 and a discount compared to peers, the overall sentiment remains cautious due to the company's historical underperformance and modest growth rates.